Growth and antigen recognition of tumor-infiltrating lymphocytes from human breast cancer.
In the present study, we isolated tumor-infiltrating lymphocytes (TIL) from 21 primary solid tumors and tumor-associated lymphocytes (TAL) from 9 malignant effusions, respectively, of breast cancer patients. Significant proliferation and expansion of T cells was observed in 23 of 30 distinct samples. TIL were isolated from primary tumors by either enzymatic digestion or mechanical disruption. The TIL cultures were initiated using OKT3 mAb in the presence of moderate concentrations (25-50 U/ml) of IL-2, followed by 100 U/ml of tumor necrosis factor (TNF)-alpha. TAL were not stimulated with OKT3 mAb, but all were successfully expanded in culture in the presence of IL-2 alone or together with TNF-alpha. Seven of nine distinct TAL grew in culture as predominantly CD4+ lines. In contrast, only 14 of 21 (66%) of primary breast TIL expanded in culture and were predominantly of CD8+ phenotype. Autologous tumor lysis was observed in seven of eight cases tested. Only one of the four TIL tested and one of the four TAL tested preferentially lysed autologous tumor. HER-2 peptide E75 (369-377) was recognized by two TIL lines of the five primary TIL tested and three of the four TAL tested. This suggests that E75 may be recognized by primary breast tumors. This may be of interest in developing vaccine strategies for therapeutic management of breast cancer.
Hudson
J M
JM
Department of Gynecologic Oncology, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Castilleja
A
A
Murray
J L
JL
Honda
T
T
Kudelka
A
A
Singletary
E
E
Wharton
J T
JT
Ioannides
C G
CG
D000937:Antigen-Antibody Reactions; D001943:Breast Neoplasms / Q000276:immunology / Q000473:pathology*; D002455:Cell Division / Q000276:immunology; D000939:Epitopes; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology / Q000473:pathology*; D016066:Pleural Effusion, Malignant / Q000276:immunology / Q000473:pathology; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D014407:Tumor Cells, Cultured
D000939:Epitopes; D018719:Erb-b2 Receptor Tyrosine Kinases